InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-29.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Discover the full record of transactions filed by MICHEL MASSON, Supervisory Board Chairman. Director active across 1 company, notably NEOLIFE. Cumulatively, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €18k. History available since 16 June 2023. The latest transaction was filed on 16 June 2023 (Acquisition). Regulator: AMF. The full history is openly available.
Declarations1 total
160,000 shares@ €0.113100.0% of flowActionEuronext Growth Paris2023DD916033
Ideal exit: 12 Mar 2024 (T+270)
1 of 1 declaration
About MICHEL MASSON
Michel Masson is the Vice Chairman of the Supervisory Board at Neolife, a company specializing in health solutions. In his role, he participates in overseeing operations and making strategic decisions. Michel brings his expertise in management and business development, contributing to Neolife's performance and growth.
